USPTO trademark

TEVA

RegisteredUSPTOWord and designClass 5

"TEVA" is a word and design mark owned by Teva Pharmaceutical Industries Ltd., filed at the USPTO on October 20, 2020. It is registered and covers class 5 (Pharmaceuticals).

View Teva Pharmaceutical Industries Ltd. portfolioGet this data via the API
Official USPTO record
TEVA trademark as filed
As filed with the USPTO
Status
Registered
Since December 19, 2023
Filed
October 20, 2020
Registered
December 19, 2023
Expires
Not recorded
Application no.
90266118
Registration no.
7249759
Office
USPTO
United States Patent and Trademark Office
Mark type
Word and design
1 class
Ownership

Who owns TEVA

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Teva Pharmaceutical Industries Ltd.

Tel Aviv, Israel

1,141 trademarks in the portfolioView company

Representative

Laurence Rickles

Goods and services

What the mark covers

The products and services TEVA is filed for, grouped by Nice class.

  • Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of registration confirmation emailed
  2. Registered-principal register
  3. Notice of acceptance of statement of use e-mailed
  4. Allowed principal register - sou accepted
  5. Statement of use processing complete
  6. Use amendment filed
  7. Teas statement of use received
  8. Notice of approval of extension request e-mailed
  9. Sou extension 4 granted
  10. Sou extension 4 filed

10 earlier steps on the official record.

Disputes

Oppositions and cancellations

Proceedings recorded against this mark by the USPTO. Reported as recorded, not legal advice.

FAQ

About TEVA

Who owns the trademark "TEVA"?

The USPTO trademark "TEVA" (application 90266118) is owned by Teva Pharmaceutical Industries Ltd.

What is the status of "TEVA"?

Its status at the USPTO is: registered.

When was "TEVA" registered?

It was registered on December 19, 2023.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull TEVA and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2c75-3f0a-74fd-8eb9-b3e9934ec9f0
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2c75-3f0a-74fd-8eb9-b3e9934ec9f0",
  "object": "trademark",
  "mark_text": "TEVA",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "90266118",
  "filing_date": "2020-10-20",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Teva Pharmaceutical Industries Ltd.",
      "entity_id": "ent_019ebbc5-6f32-7092-a649-5aaa7b712e21"
    }
  ]
}